Does ALS Start on One Side of the Body?

ALS nearly always begins in a single spot on one side of the body. In one clinicopathological study, 98% of limb-onset cases started as focal, lateralized weakness, meaning the first symptom was something like a weak right hand or a dragging left foot, not a general sense of bilateral decline.¹ That one-sided beginning is so characteristic of the disease that it shapes everything from how quickly ALS gets recognized to how it eventually spreads and what the prognosis looks like.

What the First Symptoms Usually Look Like

About two-thirds of people with ALS first notice weakness in a limb. In a review of 500 cases, 67% had limb-dominant onset, roughly 29% had bulbar-dominant onset (affecting speech, swallowing, or tongue muscles first), and about 4% had respiratory-dominant onset.² Among the limb-onset group, symptoms tend to be strikingly localized. A person might struggle to turn a key in a lock, trip over a curb with one foot, or notice that one hand’s grip has weakened for no clear reason. In a large study of 910 patients, upper-limb onset accounted for about 36% and lower-limb onset for about 37%, with the right arm slightly more often affected than the left.³

Bulbar-onset ALS does not follow the same left-right pattern. When the disease starts in the brainstem region, the earliest signs involve slurred speech, difficulty swallowing, or changes in voice quality. These muscles are controlled bilaterally by the brain, so the one-sidedness that is so striking in limb-onset ALS is less obvious with bulbar onset, though even bulbar cases can show subtle asymmetry in tongue wasting or jaw strength.

Does It Start on Your Dominant Side?

This is one of the more interesting findings in ALS research. For people whose weakness starts in an arm, there is a statistically significant tendency for it to begin on the dominant side. One study found 64% concordance between the side of onset and handedness in upper-limb cases.⁴ The logic behind this makes intuitive sense: the motor neurons serving your dominant hand are more heavily used over a lifetime, and more-active neurons may be more vulnerable to the degenerative process. However, the link disappears for lower-limb onset. Footedness did not predict which leg weakened first in that same study, and a separate analysis of 910 patients found that testing for concordance between handedness and arm onset did not reach statistical significance either.⁴

Brain imaging adds another layer to this picture. One study found that people with ALS showed disproportionate atrophy of the dominant (left) motor cortex hand area regardless of which side their limb weakness started on.⁵ Even in patients whose first weakness appeared in a left-sided limb, the left motor cortex (which controls the right side) still lost volume preferentially. This suggests that the dominant hemisphere has a baseline vulnerability in ALS that exists independently of where symptoms happen to appear first.

How Weakness Spreads From the Starting Point

Once ALS declares itself in one spot, the weakness does not jump randomly around the body. The predominant pattern is contiguous spread, meaning the disease moves outward from its origin into neighboring body regions. If it starts in your right hand, it tends to move up that arm or across to the left hand before reaching the legs or bulbar muscles. After unilateral limb onset, the next region to weaken is most often the opposite limb on the same level. In patients with arm onset, symptoms appeared significantly faster in the opposite arm, followed by the legs, with bulbar involvement typically arriving last.⁶ Patients with lower-limb onset showed the same mirroring pattern: the other leg weakened before the arms did.

Researchers describe this as “horizontal spreading,” meaning the disease crosses from one side to the other at roughly the same spinal level before climbing or descending the neuraxis. In one large cohort, patients with unilateral limb onset reported horizontal spreading about three times more often than vertical spreading. Autopsy data backs this up: when researchers examined the spinal cords of people who died with ALS, the pattern of motor neuron loss was graded radially outward from the region that had been affected first, like ripples moving away from where a stone drops in water.⁷

That said, ALS does not always follow the textbook. A meaningful minority of cases show discontiguous spread, where weakness skips over intermediate regions entirely. In one electrophysiological study, 14 of 36 patients showed non-contiguous abnormalities, with electrical signs of motor neuron damage appearing in segments that were not adjacent to the original site.⁸ In one clinical series, 30% of people with bulbar onset developed leg symptoms before arm symptoms, and 11% of people with leg onset developed bulbar symptoms before their arms weakened.⁶ These exceptions matter because they challenge the idea of a single, tidy wave of degeneration and suggest that something more complex is going on.

Why It Starts in One Spot and Spreads

The leading explanation for ALS’s focal onset and orderly spread involves misfolded proteins behaving in a way that resembles prion diseases. In ALS, a protein called TDP-43 misfolds, clumps together, and then acts as a kind of template that corrupts normally folded copies of the same protein in neighboring cells. Laboratory studies have demonstrated that TDP-43 aggregates taken from ALS brain and spinal cord tissue can trigger this chain reaction in healthy cells, producing the same kinds of abnormal protein deposits found in patients.⁹ These aggregates can spread from cell to cell, and the reaction can be serially propagated to produce ever-increasing amounts of pathological TDP-43.¹⁰

Researchers distinguish two routes by which this propagation can happen. Contiguous spread moves between physically adjacent cells without requiring a synaptic (nerve-to-nerve) connection. Network spread, by contrast, travels along connected neural circuits, potentially allowing the disease to jump between regions that are wired together even if they are not physically next to each other.¹¹ Both types appear to operate in ALS, which helps explain why the dominant pattern is orderly contiguous spread while occasional cases show the kind of leapfrog pattern that network propagation would predict.

A competing (or complementary) model, sometimes called “multifocal hits and local propagation,” proposes that the disease does not always start in just one place. Instead, independent degenerative events may fire up at multiple sites in the spinal cord, each of which then spreads locally. One electrophysiological study supporting this model found that the pattern of motor neuron damage could not be explained by a single origin point spreading outward; instead, it looked more like several small fires burning simultaneously, each expanding into its own neighborhood.⁸ Clinical and electrical measurements in a separate study confirmed that both contiguous and discontiguous patterns exist, with the contiguous pattern being far more common but the exceptions too frequent to ignore.¹²

There is also evidence that the brain, not just the spinal cord, plays an active role in initiating the process. The “dying-forward” hypothesis proposes that overactive motor neurons in the brain’s cortex damage the spinal motor neurons they connect to, rather than the degeneration starting in the periphery and working its way up. Studies using transcranial magnetic stimulation have found that the motor cortex opposite the side of symptom onset is abnormally excitable, with reduced inhibition.¹³ In people carrying genetic mutations that cause familial ALS, this cortical hyperexcitability has been detected before any clinical symptoms appear at all, suggesting it may be a cause rather than a consequence of the disease.¹⁴

Why the One-Sided Start Leads to Misdiagnosis

The focal, asymmetric nature of early ALS is precisely what makes it so easy to misdiagnose. A person who walks into a clinic with a weak, slightly wasted hand and no other neurological complaints looks, at first glance, like someone with a pinched nerve. A survey of hand surgeons found that 11% of active and retired members had actually performed nerve decompression surgery on patients who were later diagnosed with ALS.³ The procedures did nothing to help, because the problem was never in the wrist or elbow. It was in the motor neurons themselves. Middle-aged patients presenting with focal asymmetric limb weakness are frequently worked up for degenerative spinal disease before ALS enters the conversation.²

One clinical clue that distinguishes ALS from a nerve compression problem is the distribution of weakness. A carpal tunnel syndrome affects muscles controlled by the median nerve and nothing else. ALS weakness does not respect the boundaries of a single nerve. It tends to involve muscles from different nerve territories within the same limb, or to affect both upper and lower motor neuron signs (a combination of weakness with wasting and weakness with stiffness) in the same region. Clinicians looking for this pattern of mixed upper and lower motor neuron damage on the same side are on firmer diagnostic ground. Both types of degeneration are typically maximal in the same body region at onset, but they can differ in severity and in how far outward they have spread.¹⁵

ALS Variants That Also Start Asymmetrically

The one-sided beginning is not limited to classic ALS. Several recognized phenotypic variants of motor neuron disease share this feature, though they differ in how fast they progress and which motor neurons are primarily affected.

Flail arm syndrome involves progressive, predominantly proximal weakness and wasting of both arms, but it almost always starts asymmetrically. In one series, 76% of patients initially showed an asymmetric distribution of symptoms, typically starting in the distal muscles of one arm before eventually becoming more symmetric and proximal over time.¹⁶ Flail leg syndrome follows a similar script in the lower limbs, with one leg weakening before the other. A case series of familial ALS with a specific SOD1 mutation documented asymmetric lower-limb onset with late bulbar signs and longer-than-average survival.¹⁷

Primary lateral sclerosis, which predominantly affects upper motor neurons and progresses more slowly than typical ALS, also starts one-sidedly. In one review, 79% of PLS patients showed asymmetrical symptoms, and the majority eventually developed some lower motor neuron involvement after an average of about eight years. Recognizing PLS matters because its prognosis is substantially better than classic ALS, and the initial asymmetric presentation can look identical.

What the Spread Pattern Means for Prognosis

Where ALS starts and how quickly it spreads are among the strongest predictors of how the disease will unfold. Limb-onset ALS generally carries a somewhat longer survival than bulbar-onset ALS. In one study, median survival was about 51 months for limb onset compared with 37 months for bulbar onset.¹⁸ Population-based analyses have confirmed that bulbar or generalized onset is an independent predictor of shorter survival, along with advanced age.¹⁹

Speed of spread matters even more than location of onset. The time it takes for weakness to reach a second body region is strongly correlated with overall survival. In one longitudinal study, no patient with a rapid spread pattern, defined as two regions affected within three months of onset, survived beyond five years. By contrast, patients whose disease stayed confined to one region for longer had meaningfully better five-year survival rates, around 18 to 21% depending on whether onset was in the upper or lower limb.²⁰ The worst prognosis in that study went to patients whose disease started in two regions simultaneously, with a median survival of only 18 months.

This makes the asymmetric, focal nature of typical ALS not just a diagnostic feature but a prognostic one. A clearly one-sided start that stays one-sided for a while is a more favorable sign than rapid bilateral involvement. It is one reason clinicians track the timeline of symptom spread carefully at every visit.

The Ankle as an Early Warning in Lower-Limb ALS

For people whose ALS begins in a leg, the ankle appears to be a particularly early and telling site of dysfunction. Biomechanical studies of gait in motor neuron disease have identified the ankle as the first joint to lose power, with weakness at that level driving compensatory changes at the hip and knee as the body tries to maintain a functional walking pattern.²¹ A person might notice a foot drop, difficulty pushing off while walking, or repeated stumbling before any proximal weakness becomes apparent. This distal-to-proximal gradient mirrors what happens in upper-limb ALS, where fine finger movements tend to fail before shoulder strength does. The ankle finding is worth knowing because foot drop has a long list of possible causes, and ALS is not usually the first one that comes to mind. A foot drop that worsens over weeks to months, especially if accompanied by subtle wasting in the calf or twitching (fasciculations) elsewhere, warrants neurological evaluation rather than just a referral for an ankle brace.

What Brain Scans Show Beneath the Surface

Imaging studies have added a dimension to the asymmetry question that clinical exams alone cannot capture. When researchers compared the brain structure of people with ALS to healthy controls, the motor cortex on the side controlling the first affected limb consistently showed the most thinning. Upper and lower motor neuron degeneration peaked at the level and side corresponding to where the body first showed weakness.¹ But the two systems did not march in lockstep: their severity and outward spread were partially independent, meaning someone could have significant upper motor neuron damage with relatively preserved lower motor neurons on the same side, or vice versa.¹⁵

Genetic forms of ALS show their own imaging signatures before symptoms ever start. Carriers of the C9orf72 repeat expansion, the most common genetic cause of ALS, show changes in white-matter integrity and cortical thickness on brain scans while still clinically normal. These presymptomatic changes are asymmetric and concentrated in specific networks, including left-sided structures in the corpus callosum and caudate nucleus.²² Carriers of SOD1 mutations, by contrast, show a different pattern of changes, with damage concentrated in the motor pathways of the internal capsule rather than the broader cortical networks. These imaging differences hint that the seeds of the disease’s eventual lateralization may be planted long before anyone notices a weak hand or a dragging foot.

1
PubMed Central. Asymmetry in amyotrophic lateral sclerosis: Clinical, neuroimaging and histological observations
2
PubMed Central. Clinical Course of Amyotrophic Lateral Sclerosis according to Initial Symptoms: An Analysis of 500 Cases
3
The Journal of Hand Surgery. Misdiagnosis in Amyotrophic Lateral Sclerosis
4
PubMed. Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis
5
PubMed Central. Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis
6
PubMed. Patterns of symptom development in patients with motor neuron disease
7
PubMed. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?
8
PubMed. Spreading of amyotrophic lateral sclerosis lesions—multifocal hits and local propagation?
9
PubMed Central. In vitro prion-like behaviour of TDP-43 in ALS
10
Frontiers in Molecular Neuroscience. Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis
11
Experimental Neurology. Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis
12
Frontiers in Neurology. Discontiguous or Contiguous Spread Patterns Affect the Functional Staging in Patients With Sporadic Amyotrophic Lateral Sclerosis
13
PubMed. Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis
14
Brain. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
15
PubMed. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS
16
PubMed. Clinical features and differential diagnosis of flail arm syndrome
17
Frontiers in Neurology. Case report: Flail leg syndrome in familial amyotrophic lateral sclerosis with L144S SOD1 mutation
18
PubMed. Disease progression in amyotrophic lateral sclerosis: predictors of survival
19
PubMed. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study
20
PubMed. Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis
21
PubMed. Lower-limb biomechanics in motor neuron disease: a joint-level perspective of gait disruption
22
Brain. Asymmetry in amyotrophic lateral sclerosis: Clinical, neuroimaging and histological observations